AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3378560 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with levodopa and bromocriptine
Number of subjects: 702
Study 3378560 — intervention group
Group type: COMPARATOR
Intervention: Levodopa therapy
Number of subjects: 702
Study 3378560 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine monotherapy
Number of subjects: 702
Study 5811680 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid therapy with 2 litres of Ringer‐lactate solution transfused in one hour during surgery.
Number of subjects: 29
Study 5811680 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving 2 litres of Ringer‐lactate solution transfused in one hour.
Number of subjects: 29
Study 5811680 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients under varying conditions of anaesthesia and surgery.
Number of subjects: 29
Study 5811680 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery and anaesthesia conditions.
Number of subjects: 29
Study 31625118 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Rate ≤ 60 bpm
Number of subjects: 330
Study 31625118 — intervention group
Group type: COMPARATOR
Intervention: Heart Rate 61-80 bpm
Number of subjects: 330
Study 31625118 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Rate > 80 bpm
Number of subjects: 330
Study 31625118 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker use
Number of subjects: 330
Study 31625118 — intervention group
Group type: COMPARATOR
Intervention: No beta-blocker use
Number of subjects: 330
Study 27753739 — intervention group
Group type: EXPERIMENTAL
Intervention: Rutoside (600-1200 mg.d) and hydrolytic enzymes (540-1080 mg.d bromelain, 288-576 mg.d trypsin)
Number of subjects: 138
Study 27753739 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 138
Study 27753739 — intervention group
Group type: EXPERIMENTAL
Intervention: Rutoside and hydrolytic enzymes (WOB)
Number of subjects: 138
Study 25282631 — intervention group
Group type: EXPERIMENTAL
Intervention: WBV plus exercise group
Number of subjects: 159
Study 25282631 — intervention group
Group type: COMPARATOR
Intervention: Exercise group (stationary surface)
Number of subjects: 159
Study 25282631 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 159
Study 23084490 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth seat position
Number of subjects: 1002
Study 23084490 — intervention group
Group type: COMPARATOR
Intervention: Any other position (control)
Number of subjects: 1002
Study 21526985 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus case management
Number of subjects: 102
Study 21526985 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 102
Study 18305926 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA (100 mg)
Number of subjects: 16
Study 18305926 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (maintained at 0.6 per thousand)
Number of subjects: 16
Study 18305926 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-administration of MDMA and ethanol
Number of subjects: 16
Study 18305926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 17230421 — intervention group
Group type: EXPERIMENTAL
Intervention: Consecutive-day blood sampling
Number of subjects: 106
Study 17230421 — intervention group
Group type: COMPARATOR
Intervention: Single-day blood sampling
Number of subjects: 106
Study 15207663 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous placental delivery
Number of subjects: 400
Study 15207663 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual placental delivery
Number of subjects: 400
Study 11268296 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 0
Study 11268296 — intervention group
Group type: EXPERIMENTAL
Intervention: Markers of estrogen deficiency
Number of subjects: 0
Study 11268296 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized clinical approach to HRT
Number of subjects: 0
Study 9429882 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of a pneumatic tourniquet during open reduction and internal fixation of malleolar fractures
Number of subjects: 0
Study 9429882 — intervention group
Group type: COMPARATOR
Intervention: No tourniquet use (control group)
Number of subjects: 0
Study 7964515 — intervention group
Group type: EXPERIMENTAL
Intervention: CD8+ T cell clones from HIV-infected individuals
Number of subjects: 0
Study 7964515 — intervention group
Group type: COMPARATOR
Intervention: CD8+ T cell clones from healthy individuals
Number of subjects: 0
Study 3661647 — intervention group
Group type: EXPERIMENTAL
Intervention: Q-switched Nd:YAG laser treatment
Number of subjects: 105
Study 3661647 — intervention group
Group type: COMPARATOR
Intervention: Control group (no laser treatment)
Number of subjects: 105
Study 29985811 — intervention group
Group type: EXPERIMENTAL
Intervention: GlideScope video laryngoscope (GS)
Number of subjects: 70
Study 29985811 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscope (DL)
Number of subjects: 70
Study 28462880 — intervention group
Group type: EXPERIMENTAL
Intervention: Abangane support group intervention
Number of subjects: 453
Study 28462880 — intervention group
Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 453
Study 25493952 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict blood pressure control (mean arterial pressure under 92 mm Hg)
Number of subjects: 840
Study 25493952 — intervention group
Group type: COMPARATOR
Intervention: Usual blood pressure control (mean arterial pressure under 107 mm Hg)
Number of subjects: 840
Study 25493952 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict blood pressure control
Number of subjects: 840
Study 25493952 — intervention group
Group type: COMPARATOR
Intervention: Usual blood pressure control
Number of subjects: 840
Study 23548852 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary stress treatment programme (9 sessions over 3 months, including mindfulness-based stress reduction course for 2 hours a week over 8 weeks)
Number of subjects: 198
Study 23548852 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary stress treatment programme
Number of subjects: 198
Study 23548852 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual control group (12 consultations with a psychologist)
Number of subjects: 198
Study 23548852 — intervention group
Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 198
Study 23548852 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual control group
Number of subjects: 198
Study 21617185 — intervention group
Group type: EXPERIMENTAL
Intervention: Metreleptin administration for 16 weeks
Number of subjects: 0
Study 21617185 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study 19538810 — intervention group
Group type: EXPERIMENTAL
Intervention: Cosmopolitan meal
Number of subjects: 12
Study 19538810 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal-oriented meal
Number of subjects: 12
Study 19538810 — intervention group
Group type: COMPARATOR
Intervention: Convenience meal
Number of subjects: 12
Study 16717323 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravertebral TENS (50 mA, 15 Hz, continuously)
Number of subjects: 41
Study 16717323 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TENS)
Number of subjects: 41
Study 14566003 — intervention group
Group type: EXPERIMENTAL
Intervention: E5564, 3.5 mg/h x 72 h
Number of subjects: 0
Study 14566003 — intervention group
Group type: EXPERIMENTAL
Intervention: E5564, 3 mg/h x 4 h
Number of subjects: 0
Study 14566003 — intervention group
Group type: EXPERIMENTAL
Intervention: E5564, 0.5 mg/h x 4 h
Number of subjects: 0
Study 14566003 — intervention group
Group type: EXPERIMENTAL
Intervention: E5564, 252 mg after 72-h infusion
Number of subjects: 0
Study 11561386 — intervention group
Group type: EXPERIMENTAL
Intervention: Focusing attention on a single limb
Number of subjects: 52
Study 11561386 — intervention group
Group type: EXPERIMENTAL
Intervention: Focusing attention on both limbs
Number of subjects: 52
Study 11561386 — intervention group
Group type: COMPARATOR
Intervention: No-knowledge of results (KR) retention test
Number of subjects: 52
Study 11561386 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected attentional strategy
Number of subjects: 52
Study 9692702 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole + Amoxycillin + Clarithromycin (OAC)
Number of subjects: 81
Study 9692702 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate + Amoxycillin + Clarithromycin (RbAC)
Number of subjects: 81
Study 9692702 — intervention group
Group type: COMPARATOR
Intervention: OAC (intention-to-treat)
Number of subjects: 81
Study 9692702 — intervention group
Group type: COMPARATOR
Intervention: RbAC (intention-to-treat)
Number of subjects: 81
Study 7524256 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodilution (H) with Hct decreased to 30% using hydroxyethyl starch 200/05
Number of subjects: 20
Study 7524256 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 20
Study 2893190 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course prednisone therapy (60 mg/m2 per 24 h until proteinuria disappeared for 3 days, then 40 mg/m2 per 48 h until complete remission)
Number of subjects: 61
Study 2893190 — intervention group
Group type: COMPARATOR
Intervention: Standard prednisone therapy (60 mg/m2 per 24 h for 4 weeks, then 40 mg/m2 per 48 h for 4 weeks)
Number of subjects: 61
Study 2893190 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course prednisone therapy
Number of subjects: 61
Study 2893190 — intervention group
Group type: COMPARATOR
Intervention: Standard prednisone therapy
Number of subjects: 61
Study 31064359 — intervention group
Group type: EXPERIMENTAL
Intervention: HMW-HA + UC
Number of subjects: 156
Study 31064359 — intervention group
Group type: COMPARATOR
Intervention: UC
Number of subjects: 156
Study 28185318 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 37
Study 28185318 — intervention group
Group type: COMPARATOR
Intervention: Calcineurin Inhibitor (CNI)
Number of subjects: 37
Study 28185318 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 37
Study 26603745 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management of blood pressure (self-monitoring with self-titration of antihypertensive medication)
Number of subjects: 0
Study 26603745 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 25091790 — intervention group
Group type: EXPERIMENTAL
Intervention: De-escalation of empirical antimicrobial treatment
Number of subjects: 116
Study 25091790 — intervention group
Group type: COMPARATOR
Intervention: Continuation of empirical antimicrobial treatment
Number of subjects: 116
Study 21761505 — intervention group
Group type: EXPERIMENTAL
Intervention: Cingulo-opercular Set Maintenance ICN activation during working memory task
Number of subjects: 0
Study 21761505 — intervention group
Group type: EXPERIMENTAL
Intervention: Right Frontoparietal Control ICN activation during working memory task
Number of subjects: 0
Study 21761505 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Frontoparietal Control ICN activation during working memory task
Number of subjects: 0
Study 21761505 — intervention group
Group type: EXPERIMENTAL
Intervention: Default Mode ICN
Number of subjects: 0
Study 21761505 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual ICN
Number of subjects: 0
Study 21761505 — intervention group
Group type: EXPERIMENTAL
Intervention: Set Maintenance, Frontoparietal Control, and Dorsal Attention ICNs
Number of subjects: 0
Study 21761505 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Frontoparietal Control network activation
Number of subjects: 0
Study 21761505 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Frontoparietal Control and Dorsal Attention networks activation
Number of subjects: 0
Study 19842003 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient activation (measured by scores)
Number of subjects: 1067
Study 19842003 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilingual status and excellent health
Number of subjects: 1067
Study 19842003 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient activation
Number of subjects: 1067
Study 17223921 — intervention group
Group type: EXPERIMENTAL
Intervention: Suspicious PSA levels
Number of subjects: 2736
Study 17223921 — intervention group
Group type: COMPARATOR
Intervention: Suspicious DRE findings
Number of subjects: 2736
Study 17223921 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA level and PSA velocity
Number of subjects: 2736
Study 17223921 — intervention group
Group type: EXPERIMENTAL
Intervention: High-grade prostatic intraepithelial neoplasia
Number of subjects: 2736
Study 16036495 — intervention group
Group type: COMPARATOR
Intervention: Mail intervention (MIG)
Number of subjects: 636
Study 16036495 — intervention group
Group type: COMPARATOR
Intervention: Telephone intervention (TIG)
Number of subjects: 636
Study 16036495 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 636
Study 12588695 — intervention group
Group type: EXPERIMENTAL
Intervention: High folate and high vitamin B-12 intake
Number of subjects: 721
Study 12588695 — intervention group
Group type: EXPERIMENTAL
Intervention: High folate and high vitamin B-6 intake
Number of subjects: 721
Study 12588695 — intervention group
Group type: EXPERIMENTAL
Intervention: High folate and low alcohol intake
Number of subjects: 721
Study 12588695 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B-6 intake
Number of subjects: 721
Study 12588695 — intervention group
Group type: COMPARATOR
Intervention: Folate, methionine, vitamins B-6 and B-12 intake
Number of subjects: 721
Study 9472888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 279
Study 9472888 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious medical complications
Number of subjects: 279
Study 9472888 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious medical complications (after death discounted)
Number of subjects: 279
Study 7625517 — intervention group
Group type: EXPERIMENTAL
Intervention: Demonstration condition (children living with mothers)
Number of subjects: 53
Study 7625517 — intervention group
Group type: COMPARATOR
Intervention: Standard community condition (children placed with caretaker)
Number of subjects: 53
Study 2776869 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg terbutaline from a Turbuhaler inhaled as fast as possible (mean peak inspiratory flow rate = 53 l.min-1)
Number of subjects: 14
Study 2776869 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple inhalation technique with terbutaline Turbuhaler
Number of subjects: 14
Study 735294 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg intravenous Propranolol
Number of subjects: 19
Study 735294 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg intravenous Metoprolol
Number of subjects: 19
Study 31083176 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine treatment for 6 weeks
Number of subjects: 193
Study 27576099 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone conversation
Number of subjects: 39
Study 27576099 — intervention group
Group type: EXPERIMENTAL
Intervention: HelpLightning app
Number of subjects: 39
Study 27576099 — intervention group
Group type: COMPARATOR
Intervention: User manual
Number of subjects: 39
Study 26132298 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Counseling Intervention (BCI)
Number of subjects: 674
Study 26132298 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Advice (MA)
Number of subjects: 674
Study 23780457 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR booster vaccination
Number of subjects: 137
Study 23780457 — intervention group
Group type: COMPARATOR
Intervention: No vaccination (control group)
Number of subjects: 137
Study 21331970 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 94
Study 21331970 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 94
Study 21331970 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 94
Study 19783397 — intervention group
Group type: EXPERIMENTAL
Intervention: BCTS-S inhalation of 5 mg morphine HCl
Number of subjects: 10
Study 19783397 — intervention group
Group type: COMPARATOR
Intervention: BCTS-MC inhalation of 5 mg morphine HCl
Number of subjects: 10
Study 16507343 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive/behavioral group intervention
Number of subjects: 0
Study 16507343 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 0
Study 14985217 — intervention group
Group type: EXPERIMENTAL
Intervention: heptaglutamyl folic acid (323 nmol/d)
Number of subjects: 180
Study 14985217 — intervention group
Group type: EXPERIMENTAL
Intervention: monoglutamyl folic acid (262 nmol/d)
Number of subjects: 180
Study 14985217 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 180
Study 14985217 — intervention group
Group type: EXPERIMENTAL
Intervention: heptaglutamyl folic acid
Number of subjects: 180
Study 14985217 — intervention group
Group type: EXPERIMENTAL
Intervention: heptaglutamyl folic acid and monoglutamyl folic acid
Number of subjects: 180
Study 11376301 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/d pravastatin
Number of subjects: 2884
Study 11376301 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2884
Study 9210854 — intervention group
Group type: EXPERIMENTAL
Intervention: Underhand grip with dowel
Number of subjects: 0
Study 9210854 — intervention group
Group type: EXPERIMENTAL
Intervention: Overhand grip with dowel
Number of subjects: 0
Study 9210854 — intervention group
Group type: EXPERIMENTAL
Intervention: Dowel with awkwardness ratings
Number of subjects: 0
Study 9210854 — intervention group
Group type: EXPERIMENTAL
Intervention: Dumbbell with same procedure as dowel
Number of subjects: 0
Study 9210854 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall analysis of end-state comfort effect
Number of subjects: 0
Study 7971538 — intervention group
Group type: EXPERIMENTAL
Intervention: Life-style modification program (5 weekly 90-min sessions on modifying eating and exercise patterns)
Number of subjects: 66
Study 7971538 — intervention group
Group type: EXPERIMENTAL
Intervention: Life-style modification program
Number of subjects: 66
Study 7971538 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 66
Study 3528451 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-controlled probing (50 g vertical force)
Number of subjects: 25000
Study 3528451 — intervention group
Group type: COMPARATOR
Intervention: Manual probing (uncontrolled pressure)
Number of subjects: 25000
Study 30355107 — intervention group
Group type: EXPERIMENTAL
Intervention: Operator mTICI score
Number of subjects: 1130
Study 30355107 — intervention group
Group type: COMPARATOR
Intervention: Core lab mTICI score
Number of subjects: 1130
Study 30355107 — intervention group
Group type: EXPERIMENTAL
Intervention: Operator and core lab mTICI scores
Number of subjects: 1130
Study 27037161 — intervention group
Group type: EXPERIMENTAL
Intervention: I‐I‐Eye educational aid
Number of subjects: 0
Study 27037161 — intervention group
Group type: COMPARATOR
Intervention: Control aid
Number of subjects: 0
Study 24967410 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncardiac chest pain (NCCP) patients
Number of subjects: 51
Study 24967410 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 51
Study 24967410 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients with NCCP
Number of subjects: 51
Study 24967410 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with total TAS score more than 50
Number of subjects: 51
Study 22736201 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong exercise intervention
Number of subjects: 64
Study 22736201 — intervention group
Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 64
Study 15998266 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc citrate/triclosan formulation with bromochlorophene
Number of subjects: 24
Study 15998266 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc citrate/triclosan formulation without bromochlorophene
Number of subjects: 24
Study 15998266 — intervention group
Group type: COMPARATOR
Intervention: Control: proprietary fluoride toothpaste
Number of subjects: 24
Study 11986508 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine + Psychodynamic Psychotherapy
Number of subjects: 74
Study 11986508 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine alone
Number of subjects: 74
Study 11360593 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet control and insulin therapy (treated group)
Number of subjects: 98
Study 11360593 — intervention group
Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 98
Study 8685072 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (150 mg day(-1))
Number of subjects: 29
Study 8685072 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg day(-1))
Number of subjects: 29
Study 8685072 — intervention group
Group type: COMPARATOR
Intervention: Control group (TCA or neuroleptic treatment without SSRI)
Number of subjects: 29
Study 2187230 — intervention group
Group type: EXPERIMENTAL
Intervention: iopamidol
Number of subjects: 200
Study 2187230 — intervention group
Group type: EXPERIMENTAL
Intervention: iopromide
Number of subjects: 200
Study 2187230 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 200
Study 2187230 — intervention group
Group type: COMPARATOR
Intervention: Both iopamidol and iopromide
Number of subjects: 200
Study 45064 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic somatostatin (250 micrograms/h, over 2 h)
Number of subjects: 7
Study 45064 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 7
Study 31618444 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-concordant treatment
Number of subjects: 629
Study 30478103 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Climate Schools: Ecstasy and Emerging Drugs module (4 lessons over 4 weeks)
Number of subjects: 1126
Study 30478103 — intervention group
Group type: COMPARATOR
Intervention: Full dose (completed all four lessons)
Number of subjects: 1126
Study 30478103 — intervention group
Group type: COMPARATOR
Intervention: Incomplete dose (≤three lessons)
Number of subjects: 1126
Study 27469482 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) HF therapy
Number of subjects: 151